✦ LIBER ✦

A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent: The PLATINUM (A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of up to Two De Novo Coronary Artery Lesions) Trial

✍ Scribed by Gregg W. Stone; Paul S. Teirstein; Ian T. Meredith; Bruno Farah; Christophe L. Dubois; Robert L. Feldman; Joseph Dens; Nobuhisa Hagiwara; Dominic J. Allocco; Keith D. Dawkins

Book ID: 119270343
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 825 KB
Volume: 57
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2011.02.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AS-066 Japanese Patient Outcomes in the

AS-066 Japanese Patient Outcomes in the PLATINUM Randomized Trial Comparing the Platinum Chromium PROMUS Element Everolimus-Eluting Stent to the Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stent in De Novo Coronary Artery Lesions

✍ Shigeru Saito; Nobuhisa Hagiwara; Ryuta Asano; Keiichi Igarashi; Toshiya Muramat 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 243 KB

TCT-613 A Prospective Randomized Multi-C

TCT-613 A Prospective Randomized Multi-Center Trial to Assess the Everolimus-Eluting Stent System (Promus Element) for Coronary Revascularization in a Population of Unrestricted Patients

✍ Jean Fajadet; Eulogio Garcia; David Hildick-Smith; Sonia Petronio; Sigmund Silbe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 102 KB

A bioabsorbable everolimus-eluting coron

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

✍ John A Ormiston; Patrick W Serruys; Evelyn Regar; Dariusz Dudek; Leif Thuesen; M 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 399 KB

TWO-YEAR RESULTS OF THE PLATINUM RANDOMI

TWO-YEAR RESULTS OF THE PLATINUM RANDOMIZED TRIAL COMPARING PLATINUM CHROMIUM PROMUS ELEMENT AND COBALT CHROMIUM PROMUS/XIENCE V EVEROLIMUS-ELUTING STENTS IN DE NOVO CORONARY ARTERY LESIONS

✍ Gregg W. Stone; Paul Teirstein; Ian Meredith; Alain Bouchard; Didier Carrié; Hel 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Comparison of Everolimus-Eluting and Pac

Comparison of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients Undergoing Multilesion and Multivessel Intervention: The SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials

✍ Dean J. Kereiakes; Krishnankutty Sudhir; James B. Hermiller; Paul C. Gordon; Joa 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 939 KB

TCT-240: PLATINUM QCA: A Prospective, Mu

TCT-240: PLATINUM QCA: A Prospective, Multicenter Trial Assessing Clinical, Angiographic, and Intravascular Ultrasound Outcomes (9 Months) with the Novel Platinum-Chromium Thin-Strut PROMUS Element Everolimus-Eluting Stent in De Novo Coronary Stenoses

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 115 KB